Korean Market
EXCH
SAMIL PHARMACEUTICAL
★

Samil Pharmaceutical's Largest Shareholder Family Slightly Increases Stake to 25.93% via Open Market Purchase… Controlling Stability Maintained, Minimal Impact on Shareholder Value

 
OWNR
SAMIL PHARMACEUTICAL
★

Samil Pharmaceutical Non-Registered Director Han Byeong-ik Acquires 1,000 Shares via Open Market Purchase…Slight Decrease in Ownership Percentage

 
OWNR
SAMIL PHARMACEUTICAL
★

Samil Pharmaceutical's Non-Registered Executive Yoo Dam-hyang Buys 1,000 Shares at 7,490 KRW, Stake at 0.06%, Limited Shareholder Value Impact

 
EXCH
SAMIL PHARMACEUTICAL
★

SAMIL PHARMACEUTICAL Files Corporate Governance Report... Multiple Areas for Improvement Identified Including Late Shareholder Meeting Notice and No Dividends

 
EXCH
SAMIL PHARMACEUTICAL
★

Heo Yul Acquires 3,020 Shares via Open Market Purchase, Slightly Increasing Majority Stake to 25.90%

 
OWNR
SAMIL PHARMACEUTICAL
★

CEO Heo Seung-beom buys 10,000 shares at 7,922 won via open market purchase

 
EXCH
SAMIL PHARMACEUTICAL
★

Major Shareholder Heo Seung-beom Increases Stake to 25.89% with 10,000 Share Purchase

 
PERI
SAMIL PHARMACEUTICAL
★★★

Samil Pharm: Q1 2026 Consolidated Operating Loss of 8.4B KRW, Continuing Losses and Rising Debt Ratio

 
EXCH
SAMIL PHARMACEUTICAL
★

Samil Pharmaceutical: Largest shareholder's relatives increase stake via open market purchases

 
OWNR
SAMIL PHARMACEUTICAL
★

Report on Ownership of Specific Securities by Executives/Major Shareholders (No Changes)

 
EXCH
SAMIL PHARMACEUTICAL
★

Samil Pharmaceutical's Largest Shareholder Heo Seung-beom Increases Stake (Gift of 200,000 Shares)